المؤلفون: Ziegler, D, Hidvégi, T, Gurieva, I, Bongardt, S, Freynhagen, R, Sen, D, Sommerville, K, Mathieu, C, Van Gaal, L, Duyck, F, Verhaegen, A, Vets, B, Hovorka, J, Mazanec, R, Dolezil, D, Valensi, P, Le Devehat, C, Geffray, L, von Hubbenet, J, Jansen, J, Klein, C, Drescher, T, Herzner, A, Bodenschatz, R, Pfeiffer, A, Nischik, R, Bergtholdt, B, Boenninghoff, E, Stahl, H, Holst, A, Franz, P, Lehmann, R, Jermendy, G, Winkler, G, Spallone, V, Comi, G, Banga, J, Mikolajczyk Swatko, A, Fryze, W, Arciszewska, M, Semetkowska Jurkiewicz, E, Polaszewska Muszynska, M, Skowron, J, Cheta, D, Hancu, N, Ionescu Tirgoviste, C, Negriçsanu, G, Verbovaya, N, Zalevskaya, A, Ametov, A, Dedov, I, Ansiferov, M, Salvador Rodriguez, F, Baksi, A, Price, D, Simpson, K, Rayman, G

المصدر: Diabetes Care

مصطلحات موضوعية: Lacosamide, Emerging Treatments and Technologies, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Neuropathic pain, Placebo, Settore MED/13 - Endocrinologia, law.invention, Diabetic Neuropathies, Randomized controlled trial, law, Diabetes mellitus, Acetamides, Internal Medicine, Clinical endpoint, medicine, Humans, Treatment Outcome, Placebo Effect, Original Research, Advanced and Specialized Nursing, business.industry, medicine.disease, Anticonvulsant, Anesthesia, Toxicity, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946074b206c69e9a8e56fe1425a35728
https://doi.org/10.2337/dc09-1578